Morgan Stanley analyst Craig Hettenbach upgraded Doximity (DOCS) to Equal Weight from Underweight with a price target of $53, up from $33.

Morgan Stanley has upgraded Doximity (DOCS) to equal weight from underweight, citing renewed momentum in its business and conservative Q4 guidance. Read more here.

The round saw participation from Perplexity CTO Denis Yarats, Kleiner Perkins Scout Fund, Y Combinator, Snorkel AI CEO Alex ...

Canaccord Genuity on Wednesday downgraded Doximity (NYSE:DOCS) to hold from buy, noting that its shares, after a more than 30% rally following the company’s Q2 results, already reflect high ...

Doximity (DOCS – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst on November 7. Analyst Vikram ...

Doximity, Inc. (NASDAQ:DOCS – Get Free Report) shares reached a new 52-week high on Friday . The company traded as high as $57.10 and last traded at $57.10, with a volume of 272953 shares trading ...

Net income: US$44.2m (up 44% from 2Q 2024). Profit margin: 32% (up from 27% in 2Q 2024). The increase in margin was driven by higher revenue. EPS: US$0.24 (up from US$0.16 in 2Q 2024).

Tesla shares spiked in the wake of Donald Trump’s election win this week–and so did a handful of other stocks, in industries ...

Shares of Doximity (NYSE: DOCS) rocketed 35% higher as of 1:45 p.m. ET Friday, according to data provided by S&P Global ...

Record-breaking Q2 earnings, soaring revenue, and bullish analyst upgrades make Doximity the healthcare stock to watch ...

On Thursday, Doximity Inc (DOCS) stock saw a modest uptick, ending the day at $43.42 which represents a slight increase of $1.07 or 2.53% from the prior close of $42.35. The stock opened at $42.41 and ...

The online medical platform reported quarterly revenue of $136.8 million and earnings of 30 cents a share, beating analysts ...